Bionano Laboratories Sees 47% Increase in Medicare Payment for OGM Blood Cancer Test

Bionano Laboratories, a subsidiary of Bionano Genomics, has announced that the Centers for Medicare & Medicaid Services (CMS) has increased the payment for the Category I CPT code 81195 for optical genome mapping (OGM) in cytogenomic genome-wide analysis to detect structural and copy number variations related to hematologic malignancies. The payment will increase by 47%, from $1263.53 to $1853.22, effective January 1, 2026. This increase reflects a request for reconsideration and crosswalk to a different code with a higher payment rate.